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ABSTRACT
Comparative high-throughput amplified fragment length polymorphism (htAFLP) analysis was
performed on a set of 25 complement-resistant and 23 complement-sensitive isolates of Moraxella
catarrhalis in order to determine whether there were complement phenotype-specific markers within
this species. The htAFLP analysis used 21 primer-pair combinations, generating 41 364 individual
fragments and 2273 fragment length polymorphisms, with an average of 862 polymorphisms per isolate.
Analysis of polymorphism data clearly indicated the presence of two phylogenetic lineages and 40 (2%)
lineage-specific polymorphisms. However, despite the presence of 361 (16%) statistically significant
complement phenotype-associated polymorphisms, no single marker was 100% complement
phenotype-specific. Furthermore, no complement phenotype-specific marker was found within different
phylogenetic lineages. These findings agree with previous results indicating that the complement
resistance phenotype within M. catarrhalis is probably defined by multiple genes, although not all of
these genes may be present within all M. catarrhalis isolates.
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INTRODUCTION
Moraxella catarrhalis is a commensal organism in
the human respiratory tract, but is also recognised
as a pathogen for both children and adults.
Carriage rates differ widely between children
and adult populations, being c.77.5% and 2%,
respectively [1,2]. In children, the organism has
been associated with acute otitis media [3], sinus-
itis [4] and, infrequently, pneumonia [5] and
bacteraemia [6]. The maximum rate of M. catarrh-
alis colonisation appears to occur in children aged
1–48 months [7], with strains appearing to spread
among children in nursery schools and day-care
centres [8]. Nosocomial spread has also been
reported [9], although respiratory tract colonisa-
tion by a new M. catarrhalis genotype does not
necessarily result in the production of overt
disease [10]. In adults, the organism has been
associated with exacerbations of chronic obstruct-
ive airways disease ⁄ bronchitis [11,12] and pneu-
monia [13]. At the present time, there appears to
be an almost universal (> 90%) incidence of
chromosomally-encoded b-lactamase-mediated
resistance to penicillin-like antibiotics among
clinical isolates [14,15]. Previous studies using a
variety of different DNA typing techniques,
including pulsed-field gel electrophoresis (PFGE),
random amplified polymorphic DNA (RAPD)
[16], single adapter probe-generated RFLP (SAR-
FLP), probe-generated restriction fragment length
polymorphisms (pRFLP) and 16S rRNA sequen-
cing [17], have suggested that genetic lineages or
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sub-populations of M. catarrhalis exist, and that
these lineages exhibit different virulence poten-
tial, including the expression of complement-
resistant and complement-sensitive phenotypes.
However, these genotyping techniques have not
been used previously to identify complement
phenotype-specific polymorphisms per se.
Complement resistance has been established
previously as a virulence trait in M. catarrhalis
[18,19], with evidence suggesting that the mech-
anism of resistance may be facilitated via inhibi-
tion of membrane attack complex (MAC)
formation, possibly following binding of the
complement inhibitor vitronectin to the bacterial
ubiquitous surface protein A2 (UspA2) [20–25].
However, this is not the only mechanism that has
been described, as the iron-acquisition protein
CopB [26,27], a 50-kDa outer membrane protein
OmpE [28], a lipooligosaccharide P(k) epitope [29]
and a ferric uptake regulator (fur) [30] have also
been implicated in facilitating complement resist-
ance within this species. In addition, several
reports have indicated that clinical isolates of M.
catarrhalis are more likely to be complement-
resistant than are isolates obtained from healthy
individuals [31,32].
In the present study, comparative genomic
polymorphism analysis was performed on a
set of complement-resistant and complement-
sensitive isolates of M. catarrhalis in order to
determine whether there are complement resist-
ance-specific markers within this species. At the
same time, a uspA2 PCR-RFLP method was used
to provide a standard internal genetic marker for
the complement resistant ⁄ sensitive phenotype.
The identification of complement phenotype-
specific markers would: (i) help to confirm
any relationship between complement resistance
and genetic lineage; (ii) help to identify novel
complement resistance-associated genes; and
(iii) possibly assist in the development of rapid
tests (including other virulence markers) to
distinguish between virulent and non-virulent
M. catarrhalis isolates.
MATERIALS AND METHODS
Bacterial isolates
Twenty-five complement-resistant and 23 complement-sensi-
tive isolates ofM. catarrhalis were chosen from the collection of
isolates stored at )80C by the Department of Medical
Microbiology and Infectious Diseases at the Erasmus MC,
Rotterdam, The Netherlands (Table 1). These isolates had been
characterised previously by Verduin et al. [16] using several
different genotyping techniques.
Complement resistance testing
The complement-resistant or -sensitive phenotype of the 48
M. catarrhalis isolates studied was determined previously
using the culture-and-spot test by Verduin et al. [33]. This is a
rapid and simple test for determining the complement
resistance phenotype of M. catarrhalis, and exhibits a statis-
tically significant concordance with the serum bactericidal
assay. For the purposes of the present study, any isolate
Table 1. Moraxella catarrhalis isolates used in high-
throughput amplified fragment length polymorphism
(htAFLP) analysis
Isolate Origin
Complement
Phenotype
1.12 NN Resistant
1.24 NN Resistant
1.38 NN Resistant
3.9 NN Resistant
4.16 NN Resistant
7.13 NN Resistant
F5.82 HN Resistant
F6.90 HN Resistant
F6.92 HN Resistant
F1.3 HN Resistant
F2.44 HN Resistant
F3.46 HN Resistant
129822 FN Resistant
131472 FN Resistant
H2 UN Resistant
H12 UN Resistant
97 ⁄ 951 RN Resistant
97 ⁄ 0233 RN Resistant
25240 ATCC Resistant
B22 A Resistant
D14 A Resistant
F17 A Resistant
QOl A Resistant
R02 A Resistant
V02 A Resistant
1.9 NN Sensitive
1.39 NN Sensitive
3.14 NN Sensitive
3.18 NN Sensitive
3.21 NN Sensitive
3.24 NN Sensitive
4.22 NN Sensitive
5.12 NN Sensitive
6.2 NN Sensitive
6.12 NN Sensitive
7.2 NN Sensitive
7.10 NN Sensitive
8.3 NN Sensitive
F1.11 HN Sensitive
F2.42 HN Sensitive
F3.57 HN Sensitive
F4.64K HN Sensitive
F4.64N HN Sensitive
F6.93 HN Sensitive
38935 FN Sensitive
55183 FN Sensitive
60832 FN Sensitive
69982 FN Sensitive
NN, isolates from children at a primary school, Nieuwegein, The Netherlands
(1989); HN, isolates from children at a primary school, Heerenveen, The Nether-
lands (1993); FN, clinical isolates from adult lower respiratory tract infections,
Friesland, The Netherlands (1993); UN, positive blood cultures from children,
Utrecht, The Netherlands (1989); RN, positive blood cultures from children,
Rotterdam, The Netherlands (1997); ATCC, isolate from the American Type Culture
Collection; A, Ghanean isolates (1995).
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found to express an intermediate complement-resistant phe-
notype (isolates F5.82, 1.24 and F6.92) was regarded as
complement-resistant.
High-throughput AFLP analysis (htAFLP)
htAFLP analysis was performed at Keygene N.V. (Wagenin-
gen, The Netherlands), using primers labelled with radio-
active phosphorous-33 as described previously [34]. Genomic
DNA was digested using the restriction enzymes MboI
and MseI and heat-inactivated, followed by ligation of the
restriction products to MseI and MboI adapters. htAFLP
amplification was performed using: (i) an MboI primer
(5’-GTAGACTGCGTACCGATC) incorporating an extra
selective nucleotide at its 3’-end (labelled with radioactive
phosphorous-33); and (ii) an MseI primer (5’-GAC-
GATGAGTCCTGAGTAA) incorporating two extra selective
nucleotides at its 3’-end (both unlabelled). In total, 21 primer
combinations were used in the htAFLP analysis of the 48 M.
catarrhalis isolates tested (Table 2). Analysis of htAFLP gel
fingerprints used 1 lL of each htAFLP reaction, which was
loaded on a denaturing polyacrylamide sequencing gel (5%
w ⁄v) along with a radioactively-labelled internal size marker.
Fragments were separated by electrophoresis for 2 h at
constant power (110 W). After electrophoresis, gels were
fixed for 30 min in acetic acid 10% v ⁄v, dried on glass plates,
and exposed to phosphor image plates (Fuji, Rotterdam, The
Netherlands). Fingerprint patterns were visualised using a
BAS-2000 phosphor image plate scanner (Fuji) and the
scanned images were analysed using AFLP-QuantarPro
software (Keygene). Any fragment found to be present in
100% of M. catarrhalis isolates (after exclusion of equivocal
results) was discarded from the total set of fragments
generated and was not used for comparative analysis.
Phylogenetic analysis
Phylogenetic analysis of htAFLP data was performed using
two-dimensional hierarchical clustering with a complete link-
age algorithm and the Tanimoto similarity metric (OmniVizR
v.3.6 software; OmniViz Inc., Maynard, MA, USA). Similarity
was based on the number of positive attributes that two
records have in common, and the results were ordered by
construction of a dendrogram.
htAFLP polymorphic fragment sequencing
A PCR sequencing methodology was used to identify DNA
sequences associated with particular htAFLP polymorphic
fragments. Essentially, a small piece of the relevant polymor-
phic fragment was recovered from the htAFLP gel and added
directly to a PCR sequencing reaction mix containing the
relevant htAFLP linker primer. PCR sequencing was per-
formed using dye terminators on an ABI 3700 capillary
sequencer (Applied Biosystems, Warrington, UK). The
sequence data from each polymorphic fragment were then
compared with the M. catarrhalis genome sequences available
at GenBank (accession numbers AX067426 ) AX067466, com-
prising 41 contigs ranging in size from 429 to 261 300 bp in
length) in order to identify homologous open reading frame
(ORF) sequences. The corresponding homologous ORF was
then translated into protein, and the resulting protein sequence
was used to search publicly available protein sequence
databases to identify the nature of the original gene.
uspA2 PCR-RFLP
The uspA2 gene of all 48M. catarrhalis isolates was analysed by
PCR-RFLP as a means of providing an internal genetic control
for the complement-resistant or -sensitive phenotype, based on
the findings of Attia et al. [24], who revealed that a 102-amino-
acid region of the uspA2 gene was important in conferring
complement resistance in uspA2-carrying M. catarrhalis iso-
lates. Initial uspA2 gene amplification was achieved using PCR
primer pair uspA2start (5’-CGCTGTAACCAGTGCCATGA)
and uspA2end (5’-ACGATAGCCAGCACCGATAG), followed
by amplimer digestion using restriction enzyme HaeIII. Fol-
lowing gel electrophoresis, a dendrogram of the restriction
fragment patterns was constructed using BioNumerics v.3.0
software (Applied Maths, Sint-Martens-Latem, Belgium). All
uspA2 PCRs (including negative reactions) were shown to
contain PCR-amplifiableM. catarrhalis DNA via a confirmatory
ompJ PCR using primer pair 19 kDaresf (5’-CTAACGCTGC-
CATCAGCTAT) and 19 kDaresr (5’-GTTGCATTACGGCTGG-
TAAC) [35].
RESULTS
htAFLP analysis
In total, 41 364 fragments were obtained using 21
htAFLP primer combinations with a set of 48 M.
catarrhalis isolates. Further analysis revealed the
presence of 2273 different fragment length poly-
morphisms, ranging in size from 67 to 493 bp, with
an average fragment length of c. 200 bp. Using
these values, the theoretical genome coverage
of the polymorphic markers was estimated
at (2273 · 200 ⁄ 1 912 671) · 100 = 23.7%, where
1 912 671 is the number of bp present in the
unannotated M. catarrhalis genomic sequence
available at GenBank (accession numbers
AX067426 ) AX067466). The largest number of
polymorphicmarkers (176markers)was generated
Table 2. 3¢-end discriminating bases added to high-
throughput amplified fragment length polymorphism
(htAFLP) linker primers
MseI Primer
MboI primer
+A +C +G +T
+ AA +
+ AC + +
+ AG +
+ AT + +
+ CA +
+ CT + +
+ GA + +
+ GT + +
+ TA + +
+ TC + +
+ TG + +
+ TT + +
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using the selective nucleotide combination A ⁄TC,
and the fewest (61 markers) using the selective
nucleotide combination T ⁄CT.
Phylogenetic analysis
Comparative phylogenetic analysis of the htAFLP
data obtained from the 48 isolates revealed a
bifurcation in the distribution of htAFLP polymor-
phisms into two distinct phylogenetic lineages,
exhibiting c. 5% difference in their branch depth.
These two lineages were differentiated by c. 250
and 242 lineage-defining polymorphisms, respect-
ively, with 40 (1.9%) htAFLP polymorphisms
found to be 100% specific for one or the other of
the two genetic lineages identified. Twenty-three
of these lineage-specific polymorphisms mapped
to the lineage with a shorter branch depth, while
the remaining 17 polymorphisms mapped to the
lineage with the longer branch depth. Interest-
ingly, 22 of the 23 lineage 1-specific polymor-
phisms were also associated significantly with the
complement-resistant phenotype (p < 0.05), while
16 of 17 cluster 2-specific polymorphisms were
associated significantly with the complement-
sensitive phenotype. Furthermore, there was a
significant correlation between the complement
phenotype and the two phylogenetic lineages
(Fisher’s exact test, p 0.016; Pearson’s correlation
r = 0.38 (0.104–0.597), p 0.008). However, an arti-
ficial rearrangement of the isolates into comple-
ment-resistant and complement-sensitive groups
failed to reveal a polymorphism that was 100%
specific for either complement phenotype (i.e.,
found in all isolates of either the complement-
resistant or complement-sensitive phenotype
only), with both complement-resistant and com-
plement-sensitive groups clearly composed of
multiple genotypes. Furthermore, no 100%-speci-
fic complement phenotype markers could be iden-
tified, even when the genetic lineages were
considered separately. However, 361 (16%) poly-
morphisms were found to be associated signifi-
cantly with the complement phenotype at p <0.05
(Fisher’s exact test), including 172 polymorphisms
associated with complement resistance and 189
associated with complement sensitivity.
htAFLP polymorphic fragment sequencing
Using the results obtained from phylogenetic
analysis, 13 polymorphic fragments found to be
100%-associated with the genetic lineage, and 17
polymorphic fragments found to be associated
significantly with the complement phenotype,
were chosen arbitrarily and sequenced. Of the
genetic lineage-specific markers, 11 were mapped
to putative housekeeping genes, while two were
mapped to putative virulence-associated genes
(Table 3). The majority of the complement phe-
notype-associated markers that were sequenced
were found to map to putative housekeeping
genes, although polymorphic marker F3121.511
<N was found to reside within the copB gene,
which has been associated with iron-acquisition
[36], is a target for antibodies involved in pul-
monary clearance [37], and has been implicated in
altering serum resistance in vivo [26].
The sequence data for the htAFLP fragments
sequenced in this study are available from
GenBank under accession numbers AY771621–
AY771641 and AY944724–AY944731.
uspA2 PCR-RFLP
In total, 35 (73%) of the 48 isolates generated PCR
products for PCR-RFLP analysis using the
uspA2start ⁄uspA2end primer-pair combination,
although all 48 isolates were positive using a
confirmatory ompJ PCR protocol (data not
shown). Once assembled into a dendrogram,
two main clusters of uspA2 genes were observed
(Fig. 1). For the 35 isolates that yielded uspA2 PCR
amplification products, the correlation between
uspA2 PCR-RFLP cluster and complement pheno-
type was highly significant (Pearson r = 0.944
(0.888–0.972), p <0.0001), as was the correlation
between uspA2 PCR-RFLP cluster and htAFLP
genetic lineage (Pearson r = 0.542 (0.255–0.741),
p <0.0008).
DISCUSSION
Complement resistance is a virulence trait of M.
catarrhalis that appears to increase the pathogenic
potential of this organism. Furthermore, the
expression of the complement-resistant pheno-
type has been associated previously with distinct
sub-populations or lineages of isolates, and the
identification of complement phenotype-specific
markers would help to further define the rela-
tionship between complement resistance and
genetic lineage within this species. A range of
such virulence markers would also be useful in
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the development of rapid tests to distinguish
between M. catarrhalis isolates exhibiting in-
creased virulence potential, and could possibly
influence the choice of treatment (antibiotic ther-
apy vs. ‘watchful waiting’). Such markers would
also help to identify novel complement resistance-
associated genes, and the mechanisms influencing
their expression, e.g., mutations associated with
gene promoter regions or nonsense shifts in
mRNA reading-frames.
In order to achieve this aim, an intensive
genetic analysis of M. catarrhalis was performed,
utilising 2273 polymorphic markers from 48
isolates, in an attempt to identify complement
phenotype-specific markers (i.e., markers found
in 100% of either complement-resistant or com-
plement-sensitive phenotypes). However,
although phylogenetic analysis revealed several
hundred lineage-associated genetic markers, i.e.,
markers associated significantly with genetic
lineage (including 40 lineage-specific markers),
no marker was found that was 100% specific for
the complement phenotype. Furthermore, no
complement phenotype-specific marker could be
found when the two major genetic lineages were
compared separately. However, the data did
reveal a similar number of lineage-associated
and complement phenotype-associated genetic
markers, with a statistically significant correlation
between genetic lineage and complement pheno-
type, and 38 of the 40 lineage-specific markers
were also found to be associated significantly
with the complement phenotype.
The spread of complement resistance-confer-
ring genes through M. catarrhalis sub-populations
could occur via either the horizontal or vertical
(including clonal expansion of an individual
isolate) transfer of genes. It is also conceivable
that complement resistance could be conferred by
a single gene, several individual genes, or by
Table 3. High-throughput amplified fragment length (htAFLP) polymorphic fragments associated with Moraxella
catarrhalis lineage and complement phenotype
htAFLP fragment Size (bp) Lineage Putative gene description Predicted function of identified ORF Accession number
100% specific for genetic lineage
A ⁄ AC F-134.585 < Na 109 1 Probable carboxyl-terminal protease Protein metabolism AY771621
A ⁄ AC F-379.208 < Na 353 1 N-acetylglutamate synthase Protein metabolism AY771622
A ⁄ CA F-166.034 < Na 145 1 Phosphatase domain-containing protein Unknown AY771623
A ⁄ CA F-174.909 < Na 151 1 Lipid A disaccharide synthase (lpxB) Biosynthesis of lipopolysaccharide AY771624
A ⁄ CA F-177.244 < Na 163 1 Elongation factor G Protein metabolism AY771625
A ⁄ CA F-266.454 < Na 245 1 DnaJ domain-containing protein Molecular chaperone AY771626
A ⁄ GA F-189.403 < Na 160 1 Signal transduction histidine kinase Signal transduction AY771629
A ⁄ GA F-256.710 < Na 228 1 Colicin tolerance gene (tolB)# Colicin A sensitivity ⁄ resistance AY771631
A ⁄ GA F-375.414 < Na 352 1 Ferredoxin-NADP+ reductase Protect against oxidative stress AY771632
A ⁄ TC F-227.958 < Na 201 1 Lipoprotein precursor (nlpD) Cell wall formation AY771634
A ⁄ AC F-239.018 < Nb 217 2 Flavodoxin reductase Protects against oxygen radicals AY771638
A ⁄ CA F-173.831 < Nb 144 2 Putative competence factorc Bacterial competence AY771639
A ⁄ CT F-301.112 < Nb 280 2 Hypothetical protein Unknown AY771640
Associated with the complement-resistant phenotype (p <0.05)
A ⁄ CA F-315.261 < N 287 Putative monooxygenase Energy production + conversion AY771627
A ⁄ GA F-112.386 < N 86 Mg-dependent DNase DNase AY771628
A ⁄ GA F-217.923 < N 135 Response regulator (gacA) Transcription ⁄ response regulator AY771630
A ⁄ CT F-321.511 < N 29 Major outer membrane protein CopB Iron acquisition ⁄ Serum resistance AY944723
A ⁄ TC F-360.194 < N 260 Adenylosuccinate synthetase Purine ribonucleotide synthesis AY771635
A ⁄ TC F-217.777 < N 193 Macrophage infectivity potentiator protein -
Macrophage infection -
Acyl-coA dehydrogenase (intergenic)
Energy production AY771633
T ⁄ TG F-536.245 < N 501 Homoserine dehydrogenase Protein metabolism AY944724
C ⁄ TA F-194.337 < N 163 16S rRNA processing protein (RimM) Maturation of 30S rRNA AY944725
C ⁄ TA F-224.476 < N 174 Membrane fusion protein -
Cation ⁄multidrug efflux pump (intergenic)
Membrane fusion ⁄ efflux pump AY771636
G ⁄ TA F-391.095 < N 363 ParA ATPase Partitioning of bacterial plasmids AY771637
G ⁄ AT F-191.261 < N 121 Leucyl, phenylalanyl-tRNA-protein
transferase
Protein metabolism AY944726
Associated with the complement-sensitive phenotype (p <0.05)
A ⁄ AC F-316.046 < N 289 Succinate-semi-aldehydedehydmgenase Energy production+conversion AY944727
A ⁄ TC F-318.602 < N 303 Dihydrolipoamide acetyltransferase Energy production + conversion AY771641
T ⁄ AG F-168.547 < N 142 Pyridoxamine 5-phosphate oxidase Co-enzyme metabolism AY944728
C ⁄ AT F-214.578 < N 189 Guanosine-3’, 5- bis (diphosphate) Purine metabolism AY944729
G ⁄ AT F-142.047 < N 115 Replication helicase DNA unwinding AY944730
G ⁄ AT F-310.917 < N 285 Promoter for acetaldehyde
dehydrogenase II
Energy production + conversion AY944731
a also associated with the complement resistant phenotype (p <0.05).
b also associated with the complement sensitive phenotype (p <0.05).
c putative virulence gene; putative genes assigned via in-silico translation of htAFLP fragment followed by BLASTp searching (http://www.ncbi.nih.gov/BLAST/), as well as
by reference to the M. catarrhalis genome sequence available at GenBank (accession numbers AX067426 - AX067466).
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multiple genes working in cooperation. However,
if multiple genes, working in cooperation, were
required to achieve the complement-resistant
phenotype, then the likelihood of horizontal
transfer of these genes would be reduced unless
the genes were in linkage disequilibrium. From
the present results, the absence of complement
phenotype-specific markers indicates that poly-
morphisms associated with complement resist-
ance-conferring genes are spread throughout the
complement-resistant and complement-sensitive
phenotypes of M. catarrhalis, suggesting that
complement resistance is actually conferred by
multiple genes (not universally present in all
isolates), as the presence of a single homologous
complement resistance-conferring gene would
lead to gene-specific, and hence complement
resistance-specific, polymorphisms being detect-
ed. Furthermore, even if heterologous forms of
the same complement resistance-conferring gene
were found to be present within complement-
resistant and complement-sensitive isolates (as is
the case with the uspA2 gene, which may com-
prise a hybrid uspA1 ⁄uspA2 gene in up to 20% of
isolates [38]), then polymorphisms associated
with complement resistance-conferring sequences
(including hybrid sequences) would be observed.
This conclusion agrees with previous reports
suggesting that several different genes are asso-
ciated with the complement-resistant phenotype
in M. catarrhalis, although only the UspA2 (and
closely related) UspA1 proteins, to date, have
been shown to interact functionally with comple-
ment system components.
With regard to the htAFLP methodology per se,
sequence analysis of a small proportion of poly-
morphic fragments identified polymorphisms in
three putative virulence genes, indicating that the
htAFLP methodology allowed detection of poly-
morphism in virulence-associated (e.g., comple-
ment resistance-associated) genes. In addition, an
internal control PCR-RFLP strategy using a gene
associated previously with complement resistance
in M. catarrhalis (i.e., uspA2) verified the signifi-
cant association between htAFLP genetic lineage
and the complement-resistant phenotype (as
reported previously following the use of other
genotyping techniques by Verduin et al. [16] and
Bootsma et al. [17]). Finally, in-silico restriction
digestion and htAFLP analysis of the uspA2 gene
sequence of a patent M. catarrhalis isolate (Gen-
Bank accession numbers AX067426 ) AX067466)
indicated that the htAFLP protocol used in this
study would be expected to generate at least 20
bands for polymorphic marker analysis in this
gene alone. Taken together, these results show
that the htAFLP protocol used to analyse this
M. catarrhalis population yielded genotyping
results consistent with previous reports, and
was, theoretically, sufficiently sensitive to detect
polymorphic markers associated with comple-
ment resistance-conferring genes.
In the context of the development of rapid tests
to distinguish virulent M. catarrhalis isolates, 40
lineage-specific polymorphic markers and 13
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Fig. 1. Dendrogram showing the relationship between
Moraxella catarrhalis uspA2 genes after HaeIII PCR-RFLP.
The dendrogram was created using the DICE coefficient
with the band tolerance set at 1%. Of the 48 isolates tested,
13 (27%) failed to generate uspA2 PCR amplification
products, and are therefore not included in the analysis.
Isolate, M. catarrhalis isolate; Pheno, complement pheno-
type, where R = resistant and S = sensitive. * = outlier.
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genes that carry these markers, but no comple-
ment phenotype-specific markers, were identified.
Moreover, no multiplex combination of markers
(maximum of three different markers) could be
found among the 361 significant complement
phenotype markers that would distinguish com-
pletely between complement-resistant and com-
plement-sensitive isolates. htAFLP analysis does
not, therefore, appear to be a suitable methodo-
logy for identifying genetic polymorphisms that
could be useful in the development of rapid
diagnostic tests for determining the complement
resistance phenotype in M. catarrhalis.
Finally, it was found that the htAFLP strategy
tended to identify polymorphism within putative
housekeeping genes as being associated with
complement phenotype. This association is most
likely to occur as a consequence of a shared
genetic lineage among M. catarrhalis isolates
already possessing complement resistance-associ-
ated genes, and does not indicate that the putative
housekeeping genes identified are involved in
complement resistance per se.
In conclusion, the present study provides the
most detailed polymorphism analysis of the
M. catarrhalis species published to date, utilising
comparative genomic polymorphism analysis to
search for complement phenotype-specific mark-
ers within sub-populations of M. catarrhalis. The
fact that 40 lineage-specific markers, but no
complement phenotype-specific markers, were
found, suggests that M. catarrhalis utilises mul-
tiple (combinations of) genes, which may not be
present in all isolates, as a means of achieving the
complement-resistant phenotype. The study re-
vealed that M. catarrhalis is predominantly clonal
for the complement-resistant isolates tested, with
two major phylogenetic lineages. However, iso-
lates expressing the complement resistance phe-
notype may be observed within both of these
major lineages.
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